m+Medelevator.RU
← Поиск публикаций
Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology · 2025

Efficacy and safety of ultrasound-guided acupotomy in the treatment of spastic paralysis after stroke: a randomised controlled clinical trial study.

СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Wang Yinyu, Lan Yujuan, Li Xia, Zhou Qingyan, Si Yuanhong, Peng Kejiang, Liu Minghui, Yang Shuo

Аннотация

OBJECTIVE: The purpose of this study was to evaluate the efficacy and safety of ultrasound-guided acupotomy in patients with spastic paralysis after stroke.

METHODS: A simple random sampling was used to select a total of 66 patients diagnosed with spastic paralysis after stroke in the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine between June 2022 and June 2023. They were randomly divided into the ultrasound-guided acupotomy group(33 patients) and the traditional acupotomy group (33 patients). The thickness and elasticity of the biceps brachii of the affected limb and healthy limb before and after treatment were measured and compared.

RESULTS: In the comparison of the Fugl-Meyer Assessment scale score, modified Barthel Index (MBI) score, neurological deficit Chinese Stroke Scale score, brachial muscle and the posterior biceps Emean, the ultrasound-guided acupotomy group scored higher than the traditional acupotomy group (p < 0.05), and the overall efficacy of the ultrasound-guided acupotomy group was better than that of the traditional acupotomy group.

CONCLUSION: Ultrasound-guided acupotomy can better find the needle point visually and is superior to traditional treatment methods. It has good standardisation, uniformity, operability, safety and repeatability. It may provide a new potential therapy for spastic paralysis after stroke.

CLINICAL TRIAL REGISTRATION: The trial has been registered with the Chinese Clinical Trial Registry (ChiCTR2300073294).

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты